Nanoparticle Paclitaxel (Nanoxel) as a Safe and Cost-Effective Radio-Sensitizer in Locally Advanced Head and Neck Carcinoma

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"Nanoparticle Paclitaxel (Nanoxel) as a Safe and Cost-Effective Radio-Sensitizer in Locally Advanced Head and Neck Carcinoma"
written by Akshay Nigam, Anupama Sharma, Sanjeev Kumar Singh,
published by Journal of Cancer Therapy, Vol.3 No.1, 2012

has been cited by the following article(s):

[1]	Utilization of nanotechnology in targeted radionuclide cancer therapy: monotherapy, combined therapy and radiosensitization
	2021

[2]	The Improvement of Paclitaxel Cytotoxicity using Nanocellulose based Nature Resources
	2019

[3]	Pharmacokinetics of nanomedicine for breast cancer
	External Field and Radiation Stimulated Breast Cancer Nanotheranostics, 2019

[4]	Synergistic locoregional chemoradiotherapy using a composite liposome-in-gel system as an injectable drug depot
	International journal of nanomedicine, 2016

[5]	Theranostic Nanopreparations for Medicine
	AJ McGoron - World Scientific, 2014

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top